Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock
The ANDROMEDA-SHOCK Randomized Clinical Trial
IMPORTANCE Abnormal peripheral perfusion after septic shock resuscitation has been
associated with organ dysfunction and mortality. The potential role of the clinical
assessment of peripheral perfusion as a target during resuscitation in early septic shock
has not been established.
OBJECTIVE To determine if a peripheral perfusion–targeted resuscitation during early septic shock in adults is more effective than a lactate level–targeted resuscitation for reducing mortality.
DESIGN, SETTING, AND PARTICIPANTS Multicenter, randomized trial conducted at 28 intensive care units in 5 countries. Four-hundred twenty-four patients with septic shock were included between March 2017 and March 2018. The last date of follow-up was June 12, 2018.
INTERVENTIONS Patients were randomized to a step-by-step resuscitation protocol aimed at either normalizing capillary refill time (n = 212) or normalizing or decreasing lactate levels at rates greater than 20%per 2 hours (n = 212), during an 8-hour intervention period.
MAIN OUTCOMES AND MEASURES The primary outcomewas all-cause mortality at 28 days. Secondary outcomes were organ dysfunction at 72 hours after randomization, as assessed by Sequential Organ Failure Assessment (SOFA) score (range, 0 [best] to 24 [worst]); death within 90 days; mechanical ventilation–, renal replacement therapy–, and vasopressor-free days within 28 days; intensive care unit and hospital length of stay.
RESULTS Among 424 patients randomized (mean age, 63 years; 226 [53%] women), 416 (98%) completed the trial. By day 28, 74 patients (34.9%) in the peripheral perfusion group and 92 patients (43.4%) in the lactate group had died (hazard ratio, 0.75 [95%CI, 0.55 to 1.02]; P = .06; risk difference, −8.5%[95%CI, −18.2%to 1.2%]). Peripheral perfusion–targeted resuscitation was associated with less organ dysfunction at 72 hours (mean SOFA score, 5.6 [SD, 4.3] vs 6.6 [SD, 4.7]; mean difference, −1.00 [95%CI, −1.97 to −0.02]; P = .045). There were no significant differences in the other 6 secondary outcomes. No protocol-related serious adverse reactions were confirmed.
CONCLUSIONS AND RELEVANCE Among patients with septic shock, a resuscitation strategy targeting normalization of capillary refill time, compared with a strategy targeting serum lactate levels, did not reduce all-cause 28-day mortality.
|Persistent URL||dx.doi.org/10.1001/jama.2019.0071, hdl.handle.net/1765/115549|
|Journal||J A M A: The Journal of the American Medical Association|
|Note||For the ANDROMEDA-SHOCK investgators and the Latin American Intensive Care Network (LIVEN)|
Hernández, G, Ospina-Tascon, GA, Damiani, L.P., Estenssoro, E., Dubin, A, Hurtado, J, … Bakker, J. (2019). Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock. J A M A: The Journal of the American Medical Association, 321(7), 654–664. doi:10.1001/jama.2019.0071